Is Alopecia an Autoimmune Disease? Types & Causes

Alopecia areata is an autoimmune disease. Your immune system mistakenly attacks your hair follicles, causing hair to fall out in patches. It affects roughly 2.1% of people at some point in their lives, making it one of the more common autoimmune conditions. Not all types of hair loss are autoimmune, though, so the answer depends on which form of alopecia you’re dealing with.

Which Types of Alopecia Are Autoimmune

The word “alopecia” simply means hair loss, and there are several distinct types with very different causes. Alopecia areata is the autoimmune form. It causes sudden, patchy hair loss that typically starts with one or more circular bald spots that may overlap. Some people notice itching or soreness on the scalp before hair falls out.

Androgenetic alopecia, the most common cause of hair loss overall, is not autoimmune. This is ordinary male-pattern or female-pattern baldness, driven by genetics and hormones. It happens gradually: a receding hairline and bald spots in men, thinning along the crown in women. Because it’s hereditary rather than immune-driven, it behaves completely differently from alopecia areata and requires different treatment.

Other non-autoimmune forms include traction alopecia (from tight hairstyles pulling on hair roots) and telogen effluvium (widespread shedding triggered by stress, illness, or hormonal shifts). If your hair loss appeared suddenly in distinct round patches, the autoimmune form is the most likely explanation.

How the Immune System Attacks Hair Follicles

Hair follicles normally have a form of immune protection, sometimes called “immune privilege.” They produce signals that tell the immune system to leave them alone. In alopecia areata, that protection breaks down. The follicle starts displaying surface proteins that flag it as a target, while its ability to suppress local immune activity drops.

Once the follicle loses that shield, two types of immune cells do most of the damage. Helper T cells coordinate the attack, while cytotoxic T cells directly assault the follicle. These cells cluster around and inside the hair follicle, joined by natural killer cells and other inflammatory cells. The immune signaling molecule interferon-gamma plays a central role, ramping up the follicle’s visibility to the immune system and fueling a cycle of inflammation that forces the hair into its resting phase and eventually causes it to fall out.

The good news is that this attack typically doesn’t destroy the follicle itself. The root structure survives, which is why hair can regrow when the immune assault subsides.

Genetics and Triggers

Alopecia areata runs in families, and researchers have identified dozens of genes linked to the condition. Many of these belong to a gene family called the HLA complex, which controls how the immune system recognizes threats. Other associated genes are involved in inflammation and immune regulation. Notably, many of the same genes appear in other autoimmune conditions like type 1 diabetes, multiple sclerosis, and inflammatory bowel disease, which helps explain why these diseases sometimes cluster together.

Having the genetic susceptibility doesn’t guarantee you’ll develop the condition. Something usually needs to flip the switch. Emotional stress, physical injury, and illness are all suspected triggers, but in most cases there’s no clear event that sets it off. A person can carry the risk genes for decades before an episode occurs, or they may never develop symptoms at all.

Links to Other Autoimmune Conditions

People with alopecia areata are more likely to have other autoimmune diseases. Thyroid disease is one of the most common companions, particularly Hashimoto’s thyroiditis. Celiac disease, rheumatoid arthritis, vitiligo (loss of skin pigment), and type 1 diabetes also show up more frequently in people with alopecia areata than in the general population. If you’ve been diagnosed with alopecia areata, your doctor may check your thyroid levels and screen for other conditions, especially if you have additional symptoms.

How It’s Diagnosed

Diagnosis is usually straightforward. A dermatologist will examine your scalp with a handheld magnifying device called a dermatoscope, looking at the pattern of hair loss and the condition of the follicle openings. They’ll ask about your medical and family history, particularly any autoimmune diseases in close relatives.

In most cases, the distinctive round patches and the appearance of the follicles are enough to make the diagnosis without further testing. If the pattern is unusual or another condition could be causing the hair loss, your doctor may order blood tests or a small skin biopsy. A biopsy would show the characteristic clusters of immune cells surrounding the hair follicles.

Treatment Options

For limited patches of hair loss, steroid injections into the affected area are the most common first step. A dermatologist injects a low concentration of a corticosteroid directly into the bald patches, typically once a month. This calms the local immune response enough to let hair regrow. Many people see new growth within four to eight weeks of starting treatment.

For widespread or severe cases, a newer class of oral medications called JAK inhibitors has changed the treatment landscape. These drugs block the specific signaling pathways that drive the immune attack on hair follicles. Three are now FDA-approved for severe alopecia areata:

  • Baricitinib, approved in 2022 for adults. In clinical trials, about 37 to 41% of patients taking the higher dose achieved significant hair regrowth within a year.
  • Ritlecitinib, approved in 2023 for adults and adolescents 12 and older. Roughly 22 to 31% of patients saw meaningful regrowth by 24 weeks.
  • Deuruxolitinib, the most recently approved option. In trials, 38 to 42% of patients on the higher dose achieved substantial regrowth.

These medications represent the first targeted therapies for alopecia areata. Before their approval, people with severe cases had limited options. JAK inhibitors work well for many patients, but hair loss often returns if the medication is stopped, since the underlying autoimmune tendency remains.

What to Expect Over Time

Alopecia areata is unpredictable. Some people have a single episode, regrow their hair, and never lose it again. Others experience cycles of loss and regrowth over many years. A smaller number progress to alopecia totalis (complete loss of scalp hair) or alopecia universalis (loss of all body hair), though these outcomes are less common.

Factors that tend to predict a more persistent course include onset before puberty, extensive hair loss at the first episode, loss of eyebrow or eyelash hair, a strong family history of autoimmune disease, and having other autoimmune conditions. Even in long-standing cases, the follicles remain alive beneath the skin, which means regrowth is always possible if the immune attack can be controlled.